Multiple Sclerosis: Unprecedented Progress But Significant Challenges Ahead

Jessica Falco-Walter, Christian Owen, Mishu Sharma, Christopher Reggi, Mandy Yu, Travis R. Stoub, Michael A. Stein, Magnetoencephalography and New Imaging Modalities in Epilepsy. Neurotherapeutics. ,vol. 14, pp. 4- 10 ,(2017) , 10.1007/S13311-016-0506-7

Andrew L. Smith, Jeffrey A. Cohen, Le H. Hua, Therapeutic Targets for Multiple Sclerosis: Current Treatment Goals and Future Directions. Neurotherapeutics. ,vol. 14, pp. 952- 960 ,(2017) , 10.1007/S13311-017-0548-5

Jeffrey M. Gelfand, Bruce A. C. Cree, Stephen L. Hauser, Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis. Neurotherapeutics. ,vol. 14, pp. 835- 841 ,(2017) , 10.1007/S13311-017-0557-4

Maria Pia Sormani, Matteo Pardini, Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials. Neurotherapeutics. ,vol. 14, pp. 924- 933 ,(2017) , 10.1007/S13311-017-0558-3

Laura E. Baldassari, John W. Rose, Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis Neurotherapeutics. ,vol. 14, pp. 842- 858 ,(2017) , 10.1007/S13311-017-0553-8

Kedar R. Mahajan, Daniel Ontaneda, The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials. Neurotherapeutics. ,vol. 14, pp. 905- 923 ,(2017) , 10.1007/S13311-017-0561-8

Rhonda Voskuhl, Callene Momtazee, Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding Neurotherapeutics. ,vol. 14, pp. 974- 984 ,(2017) , 10.1007/S13311-017-0562-7

Lilyana Amezcua, Flavia Nelson, Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics. Neurotherapeutics. ,vol. 14, pp. 945- 951 ,(2017) , 10.1007/S13311-017-0560-9

Brandon P. Moss, Mary R. Rensel, Carrie M. Hersh, Wellness and the Role of Comorbidities in Multiple Sclerosis Neurotherapeutics. ,vol. 14, pp. 999- 1017 ,(2017) , 10.1007/S13311-017-0563-6

Burhan Z. Chaudhry, Jeffrey A. Cohen, Devon S. Conway, Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis Neurotherapeutics. ,vol. 14, pp. 859- 873 ,(2017) , 10.1007/S13311-017-0565-4